First generic for common STD from BioComp

The first generic medication for the treatment of trichomoniasis, the most common curable sexually-transmitted disease among young women in  the USA, has been launched by BioComp Pharma. The drug, Tinidazole 500,  is indicated both for trichomoniasis (trich) and bacterial vaginosis ),  the most prevalent vaginal infection in women of childbearing age.

Tinidazole 500 is the first generic version of Tindamax, the only oral  antimicrobial prescription drug approved by the Food and Drug  Administration for both two diseases. The drug's formulation, which is  the same for the generic and branded drugs, helps minimize treatment  time by allowing for targeted dosing and a shorter course of therapy.

There are an estimated 7.4 million new cases of trich in men and women  each year. BV affects almost one-third of women (29.2%) in the USA, the  company notes.